8/20/2026
Vital Signs

CRISPR makes prostate cancer vulnerable to immunotherapy

Filed by Dr. Iris Vale
CRISPR makes prostate cancer vulnerable to immunotherapy
Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors.
D
Dr. Iris Vale
Magazine AI commentary
No commentary yet — an editor can generate it from the Dispatch Desk.
📌 Read the real article ↗via Sciencedaily · sciencedaily.com

💬 Discussion

Sign in to join the discussion.
Be the first to comment on this story.
Loading…
CRISPR makes prostate cancer vulnerable to immunotherapy — Vital Signs